Literature DB >> 25945414

Oncogenic MAGEA-TRIM28 ubiquitin ligase downregulates autophagy by ubiquitinating and degrading AMPK in cancer.

Carlos T Pineda1, Patrick Ryan Potts.   

Abstract

Autophagy is commonly altered in cancer and has a complicated, but important role in regulation of tumor growth. Autophagy is often tumor suppressive in the early stages of cancer development, but contributes to the late stages of tumor growth. Because of this, putative oncogenes that modulate autophagy signaling are especially interesting. Here we discuss our recent work detailing the function of the MAGEA-TRIM28 ubiquitin ligase as an oncogene product that targets PRKAA1/AMPKα1 for ubiquitination and proteasome-mediated degradation. Degradation of AMPK, a master cellular energy sensor and regulator, by MAGEA-TRIM28 results in significantly reduced autophagy and changes in cellular metabolism, including upregulation of MTOR signaling. Overall, expression of MAGEA3 (or MAGEA6) and degradation of AMPK is sufficient to induce transformation of normal cells and promote multiple hallmarks of cancer.

Entities:  

Keywords:  AMPK; KAP1; MAGE; TRIM28; autophagy; cancer; melanoma-antigen; spermatogenesis; testis; ubiquitin

Mesh:

Substances:

Year:  2015        PMID: 25945414      PMCID: PMC4509443          DOI: 10.1080/15548627.2015.1034420

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  32 in total

1.  CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes.

Authors:  Lei Qi; Huimei Zang; Weiwei Wu; Prakash Nagarkatti; Mitzi Nagarkatti; Qinghang Liu; Jeffrey Robbins; Xuejun Wang; Taixing Cui
Journal:  J Mol Cell Cardiol       Date:  2020-06-14       Impact factor: 5.000

2.  Cancer cells activate damage-tolerant and error-prone DNA synthesis.

Authors:  Elizabeth Mutter-Rottmayer; Yanzhe Gao; Cyrus Vaziri
Journal:  Mol Cell Oncol       Date:  2016-09-19

Review 3.  TRIMs: selective recruitment at different steps of the NF-κB pathway-determinant of activation or resolution of inflammation.

Authors:  Milton Roy; Rajesh Singh
Journal:  Cell Mol Life Sci       Date:  2021-07-20       Impact factor: 9.261

Review 4.  A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases.

Authors:  Anna K Lee; Patrick Ryan Potts
Journal:  J Mol Biol       Date:  2017-03-11       Impact factor: 5.469

Review 5.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

6.  TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1.

Authors:  Loïc Lionnard; Pauline Duc; Margs S Brennan; Andrew J Kueh; Martin Pal; Francesca Guardia; Barbara Mojsa; Maria-Alessandra Damiano; Stéphan Mora; Iréna Lassot; Ramya Ravichandran; Claude Cochet; Abdel Aouacheria; Patrick Ryan Potts; Marco J Herold; Solange Desagher; Jérôme Kucharczak
Journal:  Cell Death Differ       Date:  2018-07-24       Impact factor: 15.828

7.  HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress.

Authors:  Brandt A Nichols; Nathaniel W Oswald; Elizabeth A McMillan; Kathleen McGlynn; Jingsheng Yan; Min S Kim; Janapriya Saha; Prema L Mallipeddi; Sydnie A LaDuke; Pamela A Villalobos; Jaime Rodriguez-Canales; Ignacio I Wistuba; Bruce A Posner; Anthony J Davis; John D Minna; John B MacMillan; Angelique W Whitehurst
Journal:  Cancer Res       Date:  2018-09-05       Impact factor: 12.701

8.  Regulation of MAGE-A3/6 by the CRL4-DCAF12 ubiquitin ligase and nutrient availability.

Authors:  Ramya Ravichandran; Kiran Kodali; Junmin Peng; Patrick Ryan Potts
Journal:  EMBO Rep       Date:  2019-05-24       Impact factor: 8.807

9.  Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.

Authors:  Chunli Wei; Jingliang Cheng; Boxv Zhou; Li Zhu; Md Asaduzzaman Khan; Tao He; Sufang Zhou; Jian He; Xiaoling Lu; Hanchun Chen; Dianzheng Zhang; Yongxiang Zhao; Junjiang Fu
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

10.  TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.

Authors:  Ying Xing; Qingwei Meng; Xuesong Chen; Yanbin Zhao; Wei Liu; Jing Hu; Feng Xue; Xiaoyuan Wang; Li Cai
Journal:  Oncotarget       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.